Parapyruvate Induces Neurodegeneration in C57BL/6JNarl Mice via Inhibition of the α-Ketoglutarate Dehydrogenase Complex
Open Access
- 25 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (5) , 5919-5931
Abstract
Parapyruvate is a substance commonly found in commercial dietary supplements of calcium pyruvate (DSCP) that inhibits the alpha-ketoglutarate dehydrogenase complex (KGDHC) and has been shown to induce senescence in human Hs68 cells. However, it is unknown whether parapyruvate can induce neurodegeneration. In this study, the parapyruvate content in DSCP was converted to an equivalent dose for mice and administered to the C57BL/6JNarl mice at doses around the equivalent dose for 69 days, including 5, 50, and 500 mg/kg/day. The Morris water maze (MWM) task and the active avoidance test were conducted to assess the learning and memory ability in mice, and then brain tissues were collected for biochemical analyses. The results demonstrated that parapyruvate significantly impaired the learning and memory ability, decreased the KGDHC activity, and promoted the oxidative stress and acetylcholinesterase (AChE) activity in mice in a dose-dependent manner. Additionally, parapyruvate induced Tau and phosphorylated Tau (p-Tau) aggregation at dosages >= 5 mg/kg/day and increased the myelin basic protein (MBP) expression at a dosage of 500 mg/kg/day. These results suggest that the equivalent dose of parapyruvate can induce neurodegeneration in the C57BL/6JNarl mice.Keywords
Funding Information
- National Science and Technology Council (MOST 105-2320-B-040-017-MY3)
This publication has 79 references indexed in Scilit:
- An update on the role of mitochondrial α-ketoglutarate dehydrogenase in oxidative stressMolecular and Cellular Neuroscience, 2013
- Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulationNeurobiology of Aging, 2012
- Inactivation and Reactivation of the Mitochondrial α-Ketoglutarate Dehydrogenase ComplexJournal of Biological Chemistry, 2011
- Glutaric aciduria type I and methylmalonic aciduria: Simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexusBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease MiceThe Journal of Neuroscience, 2008
- Brain protein and α‐ketoglutarate dehydrogenase complex activity in alzheimer‐s diseaseAnnals of Neurology, 1996
- The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesionsTrends in Neurosciences, 1991
- Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's diseaseMetabolic Brain Disease, 1990
- Identification and quantitation of the impurities in sodium pyruvateAnalytical Chemistry, 1986